Associate Professor of Medicine, UCSD
Internal Medicine
Dr. Tony R. Reid, MD
|
|
Give Review
Tony R. Reid practices Internal Medicine. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He received awards:"America's Top Doctors", "Top Doctors:San Diego Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California" and "CMS Meaningful Use Stage 1 Certification". Tony Reid is also published. He has 17 publications published. The lastest publication: "O3.8Early Results: "ROCKET" a phase II Study of RRx-001, a novel triple epigenetic inhibitor, Resensitization to Irinotecan in Colorectal Cancer.' Tony R. Reid is registered with Medicare and accepts Medicare payments.
Publications
- O3.8Early Results: "ROCKET" a phase II Study of RRx-001, a novel triple epigenetic inhibitor, Resensitization to Irinotecan in ColoRectal Cancer.
- Rewriting the epigenetic code for tumor resensitization: a review.
- Targeting tumors using nanoparticle platforms: a phase I study of a Systemically administered gene therapy System.
- Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results.
- Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal Cancer.
- Response to intraarterial oncolytic virotherapy with the Herpes virus NV-1020 evaluated by 18F fluorodeoxyglucose positron emission tomography and computed tomography.
- Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory coloRectal cancer metastatic to the liver.
- Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the Oral tyrosine kinase inhibitor sunitinib.
- Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal Cancer: activity, radiographic response, and survival.
- A phase I/II trial of intratumOral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.
- Developments in medical oncology and their implications for interventional radiology.
- A novel method to control severe upper GI bleeding from metastatic Cancer with a hemostatic sealant: the CoStasis surgical hemostat.
- The war on Cancer: a military perspective.
- Effects of Onyx-015 among metastatic coloRectal cancer patients that have failed prior treatment with 5-FU/leucovorin.
- Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon Cancer.
- Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of Cancer.
Schools
Stanford University
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:San Diego Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Stanford University School of Medicine
Hospital
-
UC San Diego Health
Helpful Reviews
Similar Doctors
|
|
Dr. Hatim Husain, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Murad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce I. Covner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard G. Shu, MD |
|
|
Dr. Ajay P. Sandhu, MD
This Doctor is OpenDoctor Recommended.
|